Clinical Trial Update: Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating risperidone and trazodone monotherapy and combination therapy for delirium and agitation in critically ill patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation
• Delirium

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Trazodone (trazodone)

Snippet

Sponsor: Rochester General Hospital | Conditions: Delirium, Agitation | Phase 4 | Status: WITHDRAWN